SANA
Sana Biotechnology, Inc. Common Stock
stockNASDAQ
sana biotechnology is focused on utilizing engineered cells as medicines for patients. the ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. sana is building differentiated capabilities across the spectrum of cell and gene therapy. three aspirations drive sana as we look to discover treatments for patients with poor outcomes or currently untreatable diseases. the first is the ability to repair and control the genes in any cell in the body. we are advancing novel delivery technologies with the goal of being able to deliver any payload to any cell in a specific, predictable, and repeatable manner, paving the way for next-generation in vivo gene therapy. next is the ability to differentiate pluripotent stem cells ex vivo into immune-cloaked functional cells with the aspiration of being able to replace any missing or damaged cells in the body. last is a belief we can enable broader access to ou
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.93 | 2026-09-28 | -0.68% | 0.202 |
| 1M | 3.85 | 2026-09-04 | -24.42% | 3.478 |
| 3M | 3.97 | 2026-07-06 | -26.70% | 2.395 |
| 6M | 3.22 | 2026-04-06 | -9.63% | 1.529 |
| 1Y | 3.96 | 2025-10-03 | -26.52% | 2.383 |
| 2Y | 4.23 | 2024-10-04 | -31.21% | — |
| 5Y | 20.04 | 2021-10-04 | -85.48% | 2.103 |
Sana Biotechnology, Inc. Common Stock (NASDAQ:SANA) stock price today is $2.91, and today's volume is 3,498,446. SANA is up 0.692% today. The 30 day average volume is 3.52M. SANA market cap is $871.14M with 299.36M shares outstanding.